AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

COCHLEAR LTD

133.920

-2.180-1.60%

Volume:9.70M

Turnover:1.30B

Market Cap:8.76B

PE:59.57

High:135.670

Open:135.260

Low:132.330

Close:136.100

52wk High:297.775

52wk Low:88.740

Shares:65.40M

Float Shares:65.14M

Volume Ratio:22.24

T/O Rate:14.89%

Dividend:4.30

Dividend Rate:3.21%

EPS(TTM):2.248

EPS(LYR):2.248

ROE:7.98%

ROA:9.71%

PB:5.03

PE(LYR):59.57

Loading ...

Overview Company News Filings

Cochlear FY Adjusted Net Income AUD 322.4 Million VS. Ibes Estimate AUD 303.9 Million

THOMSON REUTERS

Cochlear FY Sales AUD 2,343.4 Million VS. Ibes Estimate AUD 2,319 Million

THOMSON REUTERS

Cochlear FY Dividend AUD 3.45

THOMSON REUTERS

Cochlear Says JPMorgan Chase Acquires 5.51% Stake

MT Newswires Live

Cochlear JPMorgan Chase Ceases to be Substantial Holder

MT Newswires Live

Cochlear's Earnings Risks Have Increased Since April

Top ASX Stocks With Low Debt And Strong Earnings Growth

Simply Wall St.

Australia's Cochlear Gains on US Import Win After Investigation

Cochlear (ASX:COH) Is Down 9.1% After FDA Clearance For Osia 3 Sound Processor - Has The Bull Case Changed?

Simply Wall St.

Cochlear Confirms US Duty-Free Access for Hearing Implant Systems

MT Newswires Live

Cochlear Ltd - Cochlear Statement on US Tariff Announcement

THOMSON REUTERS

Cochlear Ltd - Will Actively Monitor and Engage in Global Trade Environment Involving Tariffs

THOMSON REUTERS

Cochlear Ltd - Confirms That it Will Continue to be Able to Import Its Hearing Implant Systems into US Duty- Free

THOMSON REUTERS

Jefferies Downgrades Cochlear to Hold from Buy; Price Target is AU$128.40

MT Newswires Live

Cochlear Stock And 2 Australian Dividend Shares For Higher Rate Markets

Simply Wall St.

Cochlear (ASX:COH) Could Be 76% Overvalued After Osia 3 FDA Clearance

Simply Wall St.

How Investors Are Reacting To Cochlear (ASX:COH) FDA Approval Of Its Rechargeable Osia 3 Processor

Simply Wall St.

Cochlear (ASX:COH) Draws Fresh Investor Attention, Is The Recovery Already Priced In?

Simply Wall St.

Australian Healthcare Stocks at Two-month High, CSL Rises over 3%

How Cochlear’s FY26 Profit Downgrade Will Impact Cochlear (ASX:COH) Investors

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/COH.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","market":"AU","secType":"STK","nameCN":"COCHLEAR LTD","latestPrice":133.92,"timestamp":1788156720000,"preClose":136.1,"halted":0,"volume":9698531,"delay":0,"changeRate":-0.016017634092579038,"nameEN":"COCHLEAR LTD","floatShares":65138365,"shares":65398462,"eps":2.248,"marketStatus":"Not Yet Opened","change":-2.18,"latestTime":"08-31 16:12:00 AEST","open":135.26,"high":135.67,"low":132.33,"amount":1298875575,"amplitude":0.024541,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.248,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":136.1,"dividendRate":0.0321,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":22.242990340857524,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"COH.AU","preClose":136.1,"auctionPrice":133.91,"auctionVolume":5737806,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156606438}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","floatShares":65138365,"roa":"9.71%","roe":"7.98%","lyrEps":2.248,"volumeRatio":22.242990340857524,"shares":65398462,"dividePrice":4.2988,"high":135.67,"amplitude":0.024541,"preClose":136.1,"low":132.33,"week52Low":88.74,"pbRate":"5.03","psRate":"3.73","week52High":297.775,"institutionHeld":0,"latestPrice":133.92,"eps":2.248,"divideRate":0.0321,"volume":9698531,"delay":0,"ttmEps":2.248,"open":135.26,"prevYearClose":257.41,"prevWeekClose":136.1,"prevMonthClose":133.92,"prevQuarterClose":121.75,"fiveDayClose":135.77,"twentyDayClose":120.74,"sixtyDayClose":100.45,"dividendPayoutRate":1.9096682506550604,"dividendGrowthYears":5,"dividendGrowthRate":0.0117647058823529,"fiveYearAvgDividendRate":0.018048554743331537},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COH.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"COH.AU","amount":1.3,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-22","defaultRemindTime":1789948800000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-14","payableDate":"2026-09-22","currency":"AUD","dateTimestamp":1789912800000,"payDate":"2026-10-14"},{"date":"2026-08-18","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-19","symbol":"COH.AU","amount":2.15,"announcedDate":"2026-02-12","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-20","name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-13","payableDate":"2026-03-20","currency":"AUD","dateTimestamp":1773838800000,"payDate":"2026-04-13"},{"date":"2026-02-13","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770937200000,"name":null,"time":"","dateTimestamp":1770901200000,"actualEps":null},{"date":"2025-09-18","symbol":"COH.AU","amount":2.15,"announcedDate":"2025-08-15","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-19","defaultRemindTime":1758153600000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-13","payableDate":"2025-09-19","currency":"AUD","dateTimestamp":1758117600000,"payDate":"2025-10-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-20","value":1.15,"currency":"AUD"},{"executeDate":"2021-09-23","recordDate":"2021-09-24","paymentDate":"2021-10-18","value":1.4,"currency":"AUD"},{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-04-21","value":1.55,"currency":"AUD"},{"executeDate":"2022-09-21","recordDate":"2022-09-23","paymentDate":"2022-10-17","value":0.87,"currency":"AUD"},{"executeDate":"2023-03-21","recordDate":"2023-03-22","paymentDate":"2023-04-14","value":1.0075,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COH.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660683437","title":"Cochlear FY Adjusted Net Income AUD 322.4 Million VS. Ibes Estimate AUD 303.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660683437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660683437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:30","pubTimestamp":1787002232,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXZ6FRRK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437689","title":"Cochlear FY Sales AUD 2,343.4 Million VS. Ibes Estimate AUD 2,319 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437689","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437689?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:30","pubTimestamp":1787002232,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXZ6FRRK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437686","title":"Cochlear FY Dividend AUD 3.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437686","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437686?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:30","pubTimestamp":1787002232,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXZ6FRRK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659705138","title":"Cochlear Says JPMorgan Chase Acquires 5.51% Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2659705138","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659705138?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:09","pubTimestamp":1786597793,"startTime":"0","endTime":"0","summary":"Cochlear  said JPMorgan Chase and its affiliates acquired 5.51% voting power in the firm on Monday, becoming a substantial holder, according to a Thursday Australian bourse filing.JPMorgan holds 3.6 million shares of the firm as of Monday.Its shares rose over 1% in recent trading on Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PGF","BK4585","UYG","LU0106831901.USD","COH.AU","FNCL","IYG","JPM","JPMO","LU2417539215.USD","LU2264538146.SGD","JPO","IYF","JPX","LU0265550946.USD","LU0976567544.SGD","IE00BYXW3230.USD","LU0211326755.USD","LU1366192091.USD","LU0689472784.USD","FTXO","LU0345769631.USD","IE00BDRTCR15.USD","LU1670627923.USD","VFH","LU0345770993.USD","LU0320765646.SGD","LU0256863902.USD","BK4534","LU0417517546.SGD","LU0683600562.USD","LU2236285917.USD","IXG","XLF","IE00B775SV38.USD","IE00BK4W5M84.HKD","IE00BWXC8680.SGD","IE00BLSP4452.SGD","LU0211331839.USD","LU2211815571.USD","TRUF","IE00BDCRKT87.USD","KBWB","IE00BJTD4N35.SGD","LU0943347566.SGD","LU2552382132.HKD","LU1917777945.USD","TFNS","LU2505996509.AUD","LU1720051108.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657693765","title":"Cochlear JPMorgan Chase Ceases to be Substantial Holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2657693765","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657693765?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:30","pubTimestamp":1786073444,"startTime":"0","endTime":"0","summary":"Cochlear (ASX:COH) said JPMorgan Chase & Co. and its affiliates ceased to be a substantial holder as of Tuesday, according to a Friday Australian bourse filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE000M9KFDE8.USD","COH.AU","KBWB","XJO.AU","IXG","GEAR.AU","GIVE.AU","TFNS","OZR.AU","IIGF.AU","IOZ.AU","SLF.AU","PGF","XAO.AU","IMLC.AU","OZF.AU","IYF","XKO.AU","LU0976567544.SGD","BEAR.AU","IISV.AU","LU0203345920.USD","LU1629891620.HKD","TRUF","QFN.AU","FNCL","FTXO","BBOZ.AU","STW.AU","LU0265550946.USD","E200.AU","IE00BJTD4N35.SGD","UYG","VAP.AU","JPX","DACE.AU","IE0034235188.USD","LU2023250330.USD","QRE.AU","JPMO","VAS.AU","LU1064131342.USD","XLF","VFH","ZYAU.AU","IYG","JPO","BK4582","EIGA.AU","LU1145028129.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655857333","title":"Cochlear's Earnings Risks Have Increased Since April","url":"https://stock-news.laohu8.com/highlight/detail?id=2655857333","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655857333?lang=en_us&edition=fundamental","pubTime":"2026-07-31 09:51","pubTimestamp":1785462660,"startTime":"0","endTime":"0","summary":"0151 GMT - Risks to Cochlear's earnings have increased since the April trading update that sparked a 41% one-day drop in the hearing-implant supplier's share price, Macquarie analysts warn. They point out that weaker U.S. consumer sentiment was a key factor in cochlear implant demand across the Australian company's 2026 fiscal year, which ended June 30. They observe that sentiment has further deteriorated since April's guidance cut, citing a recent escalation of U.S.-Iran tensions that generates further instability and potentially sticky consumer pessimism into fiscal 2027. Currency moves are also a significant headwind for revenues and gross margins, they add. Macquarie keeps a neutral rating on the stock and cuts its target price 3.4% to 115.00 Australian dollars. Shares are down 1.9% at A$119.85.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655791382","title":"Top ASX Stocks With Low Debt And Strong Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2655791382","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655791382?lang=en_us&edition=fundamental","pubTime":"2026-07-31 06:02","pubTimestamp":1785448933,"startTime":"0","endTime":"0","summary":"Low debt and strong earnings growth are two factors many investors use to define quality. Here are three ASX stocks that have both.","market":"nz","thumbnail":"https://images.simplywall.st/asset/article-cover/20757/1785393095643.jpg","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/article-cover/20757/1785393095643.jpg"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/diversified-financials/asx-qal/qualitas-shares/news/top-asx-stocks-with-low-debt-and-strong-earnings-growth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/diversified-financials/asx-qal/qualitas-shares/news/top-asx-stocks-with-low-debt-and-strong-earnings-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7121","BK7062","VAP.AU","IIGF.AU","COH.AU","FEBU","GXDW","BK7503","IOZ.AU","EIGA.AU","VAS.AU","STW.AU","PPS.AU","SLF.AU","XAO.AU","E200.AU","OZR.AU","IISV.AU","XJO.AU","XKO.AU","BEAR.AU","QAL.AU","GIVE.AU","BK7007","IMLC.AU","QRE.AU","PMDE","GEAR.AU","ZYAU.AU","BBOZ.AU","VOTE","VGFPF","BK7016","DECU","RGLO","DACE.AU","QFN.AU","JOYT","OZF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653706483","title":"Australia's Cochlear Gains on US Import Win After Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653706483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653706483?lang=en_us&edition=fundamental","pubTime":"2026-07-24 13:47","pubTimestamp":1784872030,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cochlear gains on US import win after investigation** Shares of Australia's CochlearCOH.AXup as much as 0.8% at A$113.04; among top gainers on Australian health sub-index.AXHJwhich is down 1.1%** Stock snaps six-day losing streak** Hearing implants makersaysit will continue to be able to import its hearing implant systems into the U.S. duty free after the U.S. government concludes investigation** Adds, will continue to monitor global tariffs** YTD, stock down 56.9%, including sessions' moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nL4N43Q0C4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653060317","title":"Cochlear (ASX:COH) Is Down 9.1% After FDA Clearance For Osia 3 Sound Processor - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2653060317","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653060317?lang=en_us&edition=fundamental","pubTime":"2026-07-24 10:27","pubTimestamp":1784860077,"startTime":"0","endTime":"0","summary":"Cochlear Limited recently received FDA clearance for its Osia 3 Sound Processor, a fully rechargeable active bone conduction device offering up to 30 hours of battery life, broader fitting range, enhanced sound processing and extensive wireless connectivity features for people with conductive or mixed hearing loss and single-sided deafness.\nAn interesting angle for investors is the Osia 3’s backwards compatibility and Remote Care support, which could encourage upgrades from the existing...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-is-down-91-after-fda-clearance-for-osia-3-so","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-is-down-91-after-fda-clearance-for-osia-3-so","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARTY","COH.AU","AIPO","AGIX","BK4588","QTOC","BK4585","BK7007","CHAT","LABU","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653655777","title":"Cochlear Confirms US Duty-Free Access for Hearing Implant Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2653655777","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653655777?lang=en_us&edition=fundamental","pubTime":"2026-07-24 09:00","pubTimestamp":1784854819,"startTime":"0","endTime":"0","summary":"Cochlear  said its hearing implant systems will continue to be imported into the US duty-free after the US Government's final Section 301 investigation findings retained the tariff classification covering duty-free entry for hearing implants, according to a Friday filing with the Australian bourse.The company said it will continue to monitor global tariff developments to support ongoing access to its implantable hearing solutions worldwide, per the filing.The company said it is addressing the growing need for cochlear implants by working with stakeholders to raise awareness, strengthen policy support, and expand access to hearing loss interventions, noting that only about 5% of eligible people currently receive implants, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653774497","title":"Cochlear Ltd - Cochlear Statement on US Tariff Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653774497","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653774497?lang=en_us&edition=fundamental","pubTime":"2026-07-24 07:44","pubTimestamp":1784850251,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P17Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653774492","title":"Cochlear Ltd - Will Actively Monitor and Engage in Global Trade Environment Involving Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2653774492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653774492?lang=en_us&edition=fundamental","pubTime":"2026-07-24 07:44","pubTimestamp":1784850251,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P17Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653774418","title":"Cochlear Ltd - Confirms That it Will Continue to be Able to Import Its Hearing Implant Systems into US Duty- Free","url":"https://stock-news.laohu8.com/highlight/detail?id=2653774418","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653774418?lang=en_us&edition=fundamental","pubTime":"2026-07-24 07:44","pubTimestamp":1784850251,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nFWN43P17Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653745772","title":"Jefferies Downgrades Cochlear to Hold from Buy; Price Target is AU$128.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2653745772","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653745772?lang=en_us&edition=fundamental","pubTime":"2026-07-23 18:01","pubTimestamp":1784800869,"startTime":"0","endTime":"0","summary":"Cochlear (ASX:COH) has an average rating of hold and mean price target of AU$127.13, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652233866","title":"Cochlear Stock And 2 Australian Dividend Shares For Higher Rate Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2652233866","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652233866?lang=en_us&edition=fundamental","pubTime":"2026-07-18 03:18","pubTimestamp":1784315897,"startTime":"0","endTime":"0","summary":"With Fed officials openly discussing the possibility of further rate hikes and markets pricing in a low 2.1% chance of a sizable cut, many income investors are rethinking how dependable their dividend stocks really are. Higher-for-longer rates and inflation around 2.8% to 3.0% put more pressure on balance sheets and cash flows, which can matter a lot for regular payouts. This article looks at 3 stocks from a Defensive Dividend Stocks screener that are closely tied to this backdrop, and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ann/ansell-shares/news/cochlear-stock-and-2-australian-dividend-shares-for-higher-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ann/ansell-shares/news/cochlear-stock-and-2-australian-dividend-shares-for-higher-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XAO.AU","BK7007","RIV.AU","IOZ.AU","BK7126","QRE.AU","BK4588","IMLC.AU","VAS.AU","ZYAU.AU","BK7501","OZR.AU","BK4585","QFN.AU","EIGA.AU","E200.AU","GEAR.AU","BBOZ.AU","XKO.AU","IIGF.AU","SLF.AU","BK7100","COH.AU","XJO.AU","BEAR.AU","IISV.AU","SPHQ","STW.AU","DACE.AU","OZF.AU","GIVE.AU","VAP.AU","ANN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651410989","title":"Cochlear (ASX:COH) Could Be 76% Overvalued After Osia 3 FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2651410989","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651410989?lang=en_us&edition=fundamental","pubTime":"2026-07-16 16:35","pubTimestamp":1784190901,"startTime":"0","endTime":"0","summary":"Cochlear (ASX:COH) is back in the spotlight after receiving FDA clearance for its Osia 3 Sound Processor, a new fully rechargeable bone conduction device that supports the company’s upgrade driven hearing implant model.\nSee our latest analysis for Cochlear.\nDespite the positive headlines around Osia 3, Cochlear’s recent share price return has been mixed. A 30 day gain of about 15.4% contrasts with a year to date share price decline of around 52.8% and a 1 year total shareholder return that is...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-could-be-76-overvalued-after-osia-3-fda-clea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-could-be-76-overvalued-after-osia-3-fda-clea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK7007","LABU","COH.AU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651488192","title":"How Investors Are Reacting To Cochlear (ASX:COH) FDA Approval Of Its Rechargeable Osia 3 Processor","url":"https://stock-news.laohu8.com/highlight/detail?id=2651488192","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651488192?lang=en_us&edition=fundamental","pubTime":"2026-07-15 00:38","pubTimestamp":1784047091,"startTime":"0","endTime":"0","summary":"Cochlear Limited has received FDA clearance for its Osia 3 Sound Processor, the first fully rechargeable active bone conduction sound processor, offering up to 30 hours of battery life, broader fitting ranges, and expanded connectivity including Auracast broadcast audio.\nClinical research indicating high patient satisfaction and improved speech understanding, combined with backwards compatibility for existing Osia users, positions Osia 3 as a meaningful enhancement to Cochlear’s upgrade...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/how-investors-are-reacting-to-cochlear-asxcoh-fda-approval-o","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/how-investors-are-reacting-to-cochlear-asxcoh-fda-approval-o","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","ISBC","COH.AU","BK7007","BK4211","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649007678","title":"Cochlear (ASX:COH) Draws Fresh Investor Attention, Is The Recovery Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649007678","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649007678?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:27","pubTimestamp":1783344444,"startTime":"0","endTime":"0","summary":"Cochlear (ASX:COH) is back in focus after a 2.26% share price rise, following a one year decline of 59.17%. Investors are reassessing healthcare stocks amid improving patient activity and operational execution.\nSee our latest analysis for Cochlear.\nThe recent 27.29% 1 month share price return contrasts with a 51.01% decline year to date and a 56.63% fall in the 1 year total shareholder return. Cochlear's short term momentum is improving, while longer term performance remains weak as investors...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-draws-fresh-investor-attention-is-the-recove","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-draws-fresh-investor-attention-is-the-recove","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648665536","title":"Australian Healthcare Stocks at Two-month High, CSL Rises over 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648665536","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648665536?lang=en_us&edition=fundamental","pubTime":"2026-07-03 13:48","pubTimestamp":1783057739,"startTime":"0","endTime":"0","summary":"BUZZ-Australian healthcare stocks at two-month high, CSL rises over 3%** Australian health stocks.AXHJrise as much as 2.7%, their highest level since April 22** Stocks gain more than 5% so far this week, their best level since early-November, 2022** Extends gains for a seventh consecutive week** \"Healthcare was battered in the last FY, and has been stabilising in the last couple of months, and investors are finally waking up to how cheap they are in a historical context,\" says Mark Gardner, founder and chief executive officer at MPC Markets** Shares of CSLCSL.AXand CochlearCOH.AXgain over 3% each** Sub-index down ~20% YTD, including the session's moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nL6N4350AF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","COH.AU","BK7511","BK7067","CSL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648445658","title":"How Cochlear’s FY26 Profit Downgrade Will Impact Cochlear (ASX:COH) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2648445658","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648445658?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:41","pubTimestamp":1783042914,"startTime":"0","endTime":"0","summary":"In the past few days, Cochlear Limited cut its FY26 underlying net profit guidance to A$290 million–A$330 million, citing weaker implant demand in developed markets, Middle East delivery and receivables risk, margin pressure, and higher restructuring costs.\nThis guidance downgrade highlights how operational challenges in key geographies and rising costs can alter expectations for a business often viewed as a core ASX healthcare exposure.\nWe’ll now examine how Cochlear’s reduced FY26 profit...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/how-cochlears-fy26-profit-downgrade-will-impact-cochlear-asx","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/how-cochlears-fy26-profit-downgrade-will-impact-cochlear-asx","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":107,"code":"91000000","status":"200"}]}}